Gordon Kinder - Feb 25, 2022 Form 4 Insider Report for Bluejay Diagnostics, Inc. (BJDX)

Role
Chief Financial Officer
Signature
/s/ Gordon Kinder
Stock symbol
BJDX
Transactions as of
Feb 25, 2022
Transactions value $
$0
Form type
4
Date filed
2/28/2022, 06:50 PM
Previous filing
Nov 9, 2021
Next filing
Mar 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BJDX Option to purchase common stock Award +8.07K +20.17% 48.1K Feb 25, 2022 Common Stock 8.07K $1.09 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options set forth in this table vest in three equal annual installments, subject to the grantee's continued service to the Company on each vesting date.
F2 The stock options were issued in connection with the reporting person's employment services to the Company pursuant to the employment agreement between the reporting person and the Company dated July 1, 2021.